European Society of Cardiology Congress

Ibrahim Danad, MD: PACIFIC Trial: Which Imaging Tool Has The Greatest Diagnostic Accuracy?

August 31, 2016

Video

At The European Society of Cardiology Congress 2016 (ESC), Ibrahim Danad, MD, VU University Medical Center, Amsterdam, Netherlands, explained the results from his team's PACIFIC trial, which assessed two non-invasive coronary artery imaging tools: positon emission tomography (PET) and single photon emission computed tomography (SPECT).

Pope Francis Visit Delights Docs at ESC Meeting

August 31, 2016

Article

Thousands of cardiologists and other attendees at the ESC Congress 2016 got to meet Pope Francis, who told them he marveled at the science and human mystery of the heart.

PCI: New Imaging Detects Heart Attack Patients Who Don't Need It

August 30, 2016

Article

About a quarter of patients who survived heart attacks due to blocked arteries could be treated with drugs, not invasive procedures. The trick is determining whether the blockage is cause by plaque erosion, not plaque rupture. With optical coherence tomography a team in Boston did just that.

Anselm K. Gitt, MD: DYSIS and Increased Persistent Lipid Abnormalities

August 30, 2016

Video

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Anselm Gitt, MD discussed the DYSIS program, which was designed to get an idea to see how patients were treated for secondary prevention, focusing on dyslipidemia patients.

Two Antiplatelets Equal in Head-to-Head Trial

August 30, 2016

Article

The antiplatelet drugs prasugrel and ticagrelor are both fine for dual antiplatelet therapy following acute myocardial infarctions with ST segment elevations, a Czech study found.

Study: Drug-Eluting Stents No Better than Bare Metal

August 30, 2016

Article

Drug-eluting stents are falling far short of their promises of fewer complications, improved mortality and quality of life, a study found. In the largest study ever done comparing newer drug-eluting stents to bare metal devices, Norwegian researchers found the drug stents did not show a difference in these outcomes.

Chris Cannon, MD: New Dyslipidemia Guidelines & Global Health Implications

August 30, 2016

Video

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Chris Cannon, MD, Brigham & Women's Hospital, discussed the latest changes with the dyslipidemia guidelines.

PCSK9 Inhibitors: Weaning FH Patients off Apheresis

August 29, 2016

Article

Adding a PCSK9 inhibitor to apheresis therapy worked so well in reducing LDL in patients with familial hypercholesterolemia that two-thirds of the patients stopped getting apheresis.

Michael Lincoff, MD: Lipid Levels & Cardiovascular Outcomes With CETP Inhibition

August 29, 2016

Video

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Michael Lincoff, MD, Cleveland Clinic explained results from ACCELERATE trial involving patients with high risk vascular disease who received evacetrapib on top of standard care.

Renato Delascio Lopes, MD: Living In a New Era of Anticoagulant Therapy

August 29, 2016

Video

Renato Delascio Lopes, MD, Duke University Medical Center, discussed at the European Society of Cardiology Congress 2016 (ESC), the progress of anticoagulant therapies for patients.

x